Artificial intelligence is no longer reshaping healthcare at the margins – it is rewriting the entire stack. Foundation models now outperform expert radiologists on cancer detection. AI agents are becoming the always-on personal physician for hundreds of millions of patients. Exponential biotech is collapsing decades of medical progress into single years. The question for leaders is no longer whether AI will transform health – it is whether your organization leads the curve or gets flattened by it.

In this signature keynote, Peter Diamandis takes audiences inside the AI-driven revolution rewriting the rules of healthcare, longevity, and human performance. Drawing on his work at Fountain Life, BOLD Capital Partners, and Exponential Ventures, Peter walks the complete AI healthspan stack: AI radiologists already outperforming humans on imaging; whole-body MRI screening that catches cancer years earlier than standard care; multimodal diagnostics that read your blood, your gut microbiome, and your genome in a single workflow; and the AI agents that will increasingly serve as a personal physician for every human on earth. He shares the AI-and-healthspan breakthroughs of the past 24 months that every CEO needs to know – the foundation models, the agent architectures, the regenerative-medicine pipelines, the senolytics, and the biotech-AI convergence stories most boards have never heard.

Audiences leave able to: identify the AI-healthspan technologies most likely to disrupt their industry inside the next 24 months; apply Peter’s framework for stress-testing their organization, products, and benefits against a workforce that is aging chronologically but getting younger biologically; recognize the second-order implications for insurance, retirement, talent strategy, and customer experience; and adopt the personal interventions – diagnostics, screening, lifestyle protocols – that move the needle on their own healthspan today.

This talk is built for healthcare summits, payer and provider meetings, life-sciences conferences, employee benefits and wellness events, financial-services audiences planning for longer-lived clients, and any C-suite or board audience grappling with the convergence of AI and human biology. It works equally well as an opening keynote, a closing inspirational session, or a private executive briefing.

Audiences walk away with a vivid map of the AI-and-healthspan landscape, a concrete set of next steps for their organization and their personal health, and the unmistakable feeling that the next decade will look nothing like the last – and that they now have a head start the rest of their industry doesn’t.

For the first time in human history, the science of longevity has crossed an inflection point. Gene editing, cellular reprogramming, senolytics, AI-powered diagnostics, regenerative medicine, and Yamanaka factor research are converging into a credible roadmap for adding healthy decades to the human lifespan. The question is no longer whether we can extend healthspan – it is who will benefit, when it lands, and which industries will be remade in the process.

In this keynote, Peter Diamandis – co-founder of Fountain Life and bestselling author of Life Force and the Longevity Guidebook – takes audiences inside the labs, companies, and breakthroughs that are rewriting the rules of aging. Peter walks through the complete longevity stack: the diagnostics that catch disease 10-15 years before symptoms; the supplements and peptides supported by hard data versus the ones dominated by hype; the cellular reprogramming and Yamanaka factor research moving from mice to monkeys to humans; and the AI-driven drug discovery pipelines that are compressing 10-year development timelines into 18 months. He weaves in stories from the entrepreneurs and scientists pushing the frontier – David Sinclair, George Church, Bryan Johnson, and others – alongside case studies from leading companies already redesigning their products, benefits, and strategies for a longevity-driven economy.

Audiences leave with: the most actionable longevity interventions any individual can begin this quarter (diagnostics, lifestyle protocols, and the supplements supported by real evidence); a clear strategic playbook for capturing the longevity opportunity in their industry, from pharma and insurance to financial services and consumer goods; a hopeful, evidence-backed vision of a world where one hundred is the new sixty; and a framework for translating longevity trends into product, talent, and capital decisions over the next 24 months.

Perfect for life-sciences companies, pharma and biotech meetings, financial-services and wealth-management audiences planning for longer-lived clients, retirement-focused associations, employer-coalition events, healthcare summits, and any organization whose customers, workforce, or P&L will be reshaped by the extension of healthy human lifespan.

Audiences leave inspired by a future they did not know was already arriving, equipped with practical next steps for their own health, and clear on exactly how to position their company for the most consequential demographic shift of the next 50 years.

Linear companies don’t survive exponential change. Markets that took a century to mature are being remade in 18 months. Tesla, OpenAI, SpaceX, Airbnb, and Anthropic all share a common operating system – one that scales 10x while traditional rivals fight for 10%. The leaders who learn to install that operating system inside their own organization will own the next decade. The ones who don’t will be displaced by competitors that did not exist three years ago.

Drawing on his bestseller Bold and the newly released Exponential Organizations 2.0, Peter Diamandis shares the frameworks the world’s fastest-growing companies use to scale exponentially. Audiences learn the Massive Transformative Purpose (MTP) framework that gives the most ambitious companies their gravitational pull on talent and capital; the SCALE attributes (Staff on Demand, Community and Crowd, Algorithms, Leveraged Assets, Engagement) and IDEAS attributes (Interfaces, Dashboards, Experimentation, Autonomy, Social) that power exponential organizations; and the moonshot mindset that turns the world’s biggest problems into the world’s greatest business opportunities. Peter weaves in stories from XPRIZE, Singularity University, and the 25+ companies he has personally founded – Zero Gravity Corporation, International Space University, Human Longevity Inc., Celularity, Planetary Resources, and BOLD Capital Partners – giving leaders a hands-on playbook for bold innovation, intelligent risk-taking, and decisive execution.

Audiences leave with: a concrete framework for stress-testing their own organization against the ExO model; a checklist of the operating-system upgrades most likely to unlock 10x growth in their industry; a Massive Transformative Purpose worth waking up for; and a set of bold-thinking exercises leaders can run with their teams the day they get back to the office.

Ideal as an opening keynote for sales kickoffs, leadership summits, board offsites, innovation conferences, annual partner meetings, and global town halls where the goal is to permanently shift the entire organization’s ambition curve upward and equip leaders to compete in markets being rewritten by AI and exponential technologies.

Audiences walk out of this keynote with the language, frameworks, and mindset to stop incrementing – and start compounding. By the time they leave the room, the conversation about what is possible inside their organization will have permanently shifted upward.

What is coming next – and what should leaders do about it? In a world where AI capability is doubling every six months, where robotics is moving from the factory floor into the home, and where biotech is collapsing into the same exponential curve, the leaders who win the next decade will be the ones who can see around corners. The leaders who plan for what was true last year will keep getting blindsided.

In this forward-looking keynote, Peter Diamandis walks audiences through the converging exponential technologies – AI, robotics, AR/VR, sensors, networks, biotech, energy, and quantum – that are reshaping every industry over the next ten years. Peter decodes the metatrends that emerge when these technologies collide: the rise of AI agents and autonomous everything; the demonetization of healthcare, education, and energy; the death of distance; the multi-planetary species; the reinvention of work, education, and entertainment; the abundance of clean energy; the emergence of brain-computer interfaces; and the convergence of AI with biotech that will redesign the human experience itself. Built from the same intelligence Peter shares with the founders and CEOs of the world’s most important companies through his Metatrends newsletter (read by 140,000+ leaders), this talk gives audiences a 10-year head start on the trends that will define the next decade – along with the second-order implications most strategists are missing today.

Audiences leave with: a clear-eyed map of the eight to ten metatrends most likely to remake their industry; a framework for translating those trends into product roadmaps, capital allocation decisions, and talent strategies for the next 24 months; the ability to identify which competitors and which adjacent markets are most likely to attack their core; and a sharper instinct for which moonshots to pursue and which to politely defer.

Best for board meetings, executive summits, annual planning offsites, partner kickoffs, customer advisory councils, and any audience that needs to see around corners and plan for what is coming next – not what was true last year. Equally strong as an opening keynote, a closing strategic session, or a private board-level briefing.

Audiences leave with the rare gift of perspective – and the strategic clarity to act on it before their competitors realize the rules of the game have already changed.